Zhejiang Orient Gene Biotech Co.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 182.92 million compared to CNY 376.05 million a year ago. Revenue was CNY 182.92 million compared to CNY 376.05 million a year ago.

Net loss was CNY 67.35 million compared to CNY 50.33 million a year ago. Basic loss per share from continuing operations was CNY 0.33 compared to CNY 0.3 a year ago. Diluted loss per share from continuing operations was CNY 0.33 compared to CNY 0.3 a year ago.